Target Price Review on Opexa Therapeutics, Inc. (NASDAQ:OPXA)

Let’s take a brief check on where covering Street analysts see Opexa Therapeutics, Inc. (NASDAQ:OPXA) moving in the near-term. Analysts taken into consideration by Thomson Reuters have a current consensus target on company shares of $7.6700. It is useful to remember that target price projections can greatly vary from analyst to analyst. Covering analysts use their deep knowledge and expertise to help create their best calculation of where they think shares could be moving in the future. 

In order to arrive at a price target, analysts and investors alike use various metrics to determine where the stock might be headed. One of the most common is the Price to Earnings Ratio or P/E Ratio. This is calculated by taking the current share price and dividing it by the forecasted earnings per share. As of writing, Opexa Therapeutics, Inc. has a price to earnings ratio of N/A. Taking a step further, investors can also look to a firm’s price to earnings growth or PEG ratio. The PEG ratio represents the ratio of the price to earnings to the expected future growth rate of the company. A company with a PEG ratio greater than one might be considered overvalued using this metric alone. On the other hand if a firm has a PEG below one could be considered undervalued. A PEG that is close to one, is often considered fair value. The stock has a current PEG of 0.0000.

Some other technicals to consider would be the moving averages of the company. In comparing the current price level of the equity to their moving averages, the shares are trading $-0.9659 off of the 50-day average of $1.9083 and $-2.3267 away from the 200-day moving average of $3.2691.

Another important factor to consider when evaluating a stock’s current and future value are the 52 week high and low levels. As of the most recent bid at the time of writing, Opexa Therapeutics, Inc. shares are trading -80.8840% away from the 52-week high mark of 4.9299 and +88.4800% off the 52-week bottom of 0.5000. 

COMMENTS